|
WO2015137750A1
|
|
Novel compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the same
|
|
KR20160096376A
|
|
Ophthalmic composition comprising hyaluronic acid, mineral oil and surfactants
|
|
KR20150024370A
|
|
Anti-ErbB2 Antibody Variants
|
|
KR20160079178A
|
|
Solid Preparation Comprising Silodosin for Oral Administration
|
|
KR20160082640A
|
|
Pharmaceutical composition comprising granules containing an active ingredient with adjusted diameter size
|
|
KR20160070231A
|
|
adhesive tape dispense
|
|
KR20160054317A
|
|
Pharmaceutical Compositions Comprising Lobeglitazone for Oral Administration
|
|
KR101579073B1
|
|
ointment dispenser which the applicator in each
|
|
KR101579074B1
|
|
Clip for fixing button and apparatus for assembling the clip
|
|
KR20160010962A
|
|
PHARMACEUTICAL COMPOSITION COMPRISING 5-α REDUCTASE INHIBITOR
|
|
KR20160008873A
|
|
Novel beta-sulfinamino malonate derivatives and process for preparing the same, and process for preparing sitagliptin using the same
|
|
WO2014208975A1
|
|
Container assembly having means for accommodating cleaning member
|
|
MX2015014962A
|
|
Novel compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the same.
|
|
KR20140120834A
|
|
Methods for screening therapeutics for Charcot-Marie-Tooth diseases and autologous differentiated motor neurons therefor
|
|
KR20150111686A
|
|
Pharmaceutical Preparation Comprising Telmisartan and (S)-Amlodipine with Improved Oxidative Stability.
|
|
KR20150098478A
|
|
Novel method for preparing crystal form γ of silodosin
|
|
KR20150081132A
|
|
Indole Derivatives Compound, and the pharmaceutical composition comprising the same
|
|
KR20150075679A
|
|
Process for preparing alpha-hydroxy-beta-amino acid derivatives
|
|
KR20140104341A
|
|
Pharmaceutical composition consisting of sustained-release pellets
|
|
NZ704807A
|
|
N-acylhydrazone derivatives for selective t cell inhibitor and anti-lymphoid malignancy drug
|
